812546619	812546619	CD	B-NP	O
|	|	NNP	I-NP	B-cell_type
UGPMC	UGPMC	NNP	I-NP	I-cell_type
|	|	VBD	B-VP	O
72677487	72677487	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4650326	4650326	CD	B-NP	O
|	|	CC	I-NP	O
10/25/2007	10/25/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
|	|	NN	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/25/2007	9/25/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/14/2007	3/14/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
ABERCROMBIE	ABERCROMBIE	NNP	B-NP	O
,	,	,	O	O
PAT	PAT	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Ascites	Ascite	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Ascites	Ascite	NNS	B-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Prostate	Prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
today	today	NN	B-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputations	amputation	NNS	I-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
metastatic	metastatic	JJ	B-NP	O
prostate	prostate	NN	I-NP	O
cancer	cancer	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
ascites	ascite	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
since	since	IN	B-SBAR	O
his	his	PRP$	B-NP	O
last	last	JJ	I-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
in	in	IN	B-PP	O
9/24	9/24	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
noticed	notice	VBN	I-VP	O
increased	increase	VBN	B-NP	O
abdominal	abdominal	JJ	I-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
smaller	small	JJR	B-ADJP	O
after	after	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
jaundice	jaundice	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
some	some	DT	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
preoperative	preoperative	JJ	I-NP	O
area	area	NN	I-NP	O
for	for	IN	B-PP	O
revision	revision	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
poor	poor	JJ	B-NP	O
wound	wound	NN	I-NP	O
healing	healing	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
preoperative	preoperative	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noticed	notice	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medicine	medicine	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
and	and	CC	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
at	at	IN	B-PP	O
Inna	Inna	NNP	B-NP	O
Sko	Sko	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Prostate	Prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
two-vessel	two-vessel	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
stents	stent	NNS	I-NP	O
in	in	IN	B-PP	O
5/22	5/22	CD	B-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputations	amputation	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diabetic	diabetic	JJ	B-NP	O
ulcers	ulcer	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
subthalamic	subthalamic	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
in	in	IN	B-PP	O
8/06	8/06	CD	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
-	-	HYPH	B-ADVP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lyrica	Lyrica	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
twice	twice	RB	B-ADVP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Phospho	Phospho	NNP	B-NP	O
1334	1334	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
multiple	multiple	JJ	B-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
unemployed	unemployed	JJ	B-ADJP	O
.	.	.	O	O

Former	Former	JJ	B-NP	O
smoker	smoker	NN	I-NP	O
,	,	,	O	O
45	45	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
illicit	illicit	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
wife	wife	NN	B-NP	O
in	in	IN	B-PP	O
OK	OK	NNP	B-NP	O
He	He	NNP	I-NP	O
has	have	VBZ	B-VP	O
five	five	CD	B-NP	O
daughters	daughter	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
lives	life	NNS	I-NP	O
in	in	IN	B-PP	O
local	local	JJ	B-NP	O
area	area	NN	I-NP	O
and	and	CC	O	O
provide	provide	VBP	B-VP	O
help	help	NN	B-NP	O
and	and	CC	I-NP	O
support	support	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
daughter	daughter	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapist	therapist	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
96.4	96.4	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
90	90	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
110/68	110/68	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-NP	O
,	,	,	I-NP	O
mucous	mucous	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
is	be	VBZ	B-VP	O
moist	moist	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
scleral	scleral	JJ	I-NP	O
icterus	icterus	NN	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
with	with	IN	B-PP	O
prominent	prominent	JJ	B-NP	O
V	V	NN	I-NP	O
waves	wave	NNS	I-NP	O
,	,	,	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
height	height	NN	B-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
wheezes	wheeze	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rhonchi	rhonchi	NN	B-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
left	left	JJ	B-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
plus	plus	CC	O	O
RV	RV	NN	B-NP	O
heave	heave	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Tense	Tense	NN	B-NP	O
,	,	,	O	O
distended	distended	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
wave	wave	NN	I-NP	O
,	,	,	O	O
normoactive	normoactive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	VBP	B-VP	O
bilateral	bilateral	JJ	B-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputations	amputation	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
addressed	address	VBN	B-VP	O
with	with	IN	B-PP	O
gauze	gauze	NN	B-NP	O
.	.	.	O	O

SKIN	SKIN	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
rashes	rash	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ecchymosis	ecchymosis	NN	I-NP	O
or	or	CC	I-NP	O
petechiae	petechiae	NN	I-NP	O
.	.	.	O	O

NEUROLOGIC	NEUROLOGIC	NN	B-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Nonfocal	Nonfocal	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

NOTABLE	NOTABLE	NNP	B-NP	O
LABORATORY	LABORATORY	NNP	I-NP	O
VALUES	VALUES	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
133	133	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.2	5.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
88	88	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
44	44	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
6.4	6.4	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
178	178	CD	I-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
24	24	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
284	284	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.7	0.7	CD	I-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.2	0.2	CD	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
protein	protein	NN	I-NP	O
8.1	8.1	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
4.1	4.1	CD	I-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
9.1	9.1	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
7.25	7.25	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
45.1	45.1	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
189	189	CD	B-NP	O
.	.	.	O	O

Ascites	Ascites	NN	B-NP	O
fluid	fluid	NN	I-NP	O
with	with	IN	B-PP	O
2.3	2.3	CD	B-NP	O
albumin	albumin	NN	I-NP	O
,	,	,	O	O
4.3	4.3	CD	B-NP	O
total	total	JJ	I-NP	O
protein	protein	NN	I-NP	O
.	.	.	O	O

Serum	Serum	NN	B-NP	O
ascites	ascite	NNS	I-NP	O
:	:	:	O	O
Albumin	Albumin	NN	B-NP	O
gradient	gradient	NN	I-NP	O
equals	equal	VBZ	B-VP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
460	460	CD	B-NP	O
with	with	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
1230	1230	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Gram	Gram	NN	B-NP	O
stain	stain	VBP	B-VP	O
negative	negative	JJ	B-NP	O
,	,	,	I-NP	O
culture	culture	NN	I-NP	O
negative	negative	JJ	I-NP	O
.	.	.	O	O

NOTABLE	NOTABLE	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
,	,	,	O	O
8/10/2007	8/10/2007	CD	B-NP	O
:	:	:	O	O
Gallstones	Gallstone	NNS	B-NP	O
with	with	IN	B-PP	O
extrahepatic	extrahepatic	JJ	B-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
measuring	measure	VBG	B-VP	O
8	8	CD	B-NP	O
mm	mm	NN	I-NP	O
.	.	.	O	O

Large	Large	JJ	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
was	be	VBD	B-VP	O
marked	mark	VBN	I-VP	O
for	for	IN	B-PP	O
paracentesis	paracentesis	NN	B-NP	O
.	.	.	O	O

Patent	Patent	NN	B-NP	O
portal	portal	JJ	I-NP	O
and	and	CC	I-NP	O
hepatic	hepatic	JJ	I-NP	O
veins	vein	NNS	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
direction	direction	NN	I-NP	O
of	of	IN	B-PP	O
flow	flow	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
,	,	,	O	O
9/5/2007	9/5/2007	CD	B-NP	O
:	:	:	O	O
Ejection	Ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

Interventricular	Interventricular	JJ	B-NP	O
septum	septum	NN	I-NP	O
flattened	flatten	VBD	B-VP	O
in	in	IN	B-PP	O
diastole	diastole	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Mild-to-moderate	Mild-to-moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

Moderately	Moderately	RB	B-NP	O
dilated	dilate	VBN	I-NP	O
right	right	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
.	.	.	O	O

Mild-to-moderate	Mild-to-moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Moderate-to-severe	Moderate-to-severe	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
mm	mm	NN	I-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Dilated	Dilate	VBN	B-NP	O
inferior	inferior	JJ	I-NP	O
vena	vena	NN	I-NP	O
cava	cava	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
1/5/2007	1/5/2007	CD	B-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
lung	lung	NN	I-NP	O
volume	volume	NN	I-NP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
subsegmental	subsegmental	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Finger	Fing	JJR	B-NP	O
films	film	NNS	I-NP	O
,	,	,	O	O
1/5/2007	1/5/2007	CD	B-NP	O
:	:	:	O	O
Mild	Mild	NNP	B-NP	O
first	first	RB	B-NP	O
carpometacarpal	carpometacarpal	JJ	I-NP	O
and	and	CC	I-NP	O
scaphotrapeziotrapezoid	scaphotrapeziotrapezoid	JJ	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
;	;	:	O	O
otherwise	otherwise	RB	B-NP	O
unremarkable	unremarkable	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
digit	digit	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
7/5/2007	7/5/2007	CD	B-NP	O
:	:	:	O	O
Bibasilar	Bibasilar	JJ	B-NP	O
subsegmental	subsegmental	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
,	,	,	O	O
greater	great	JJR	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
,	,	,	O	O
again	again	RB	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

Unchanged	Unchanged	JJ	B-NP	O
study	study	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
9/12/2007	9/12/2007	CD	B-NP	O
:	:	:	O	O
Ejection	Ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
29	29	CD	I-NP	O
mm	mm	NN	I-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
9/25/2007	9/25/2007	CD	B-NP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
:	:	:	O	O
9/25/2007	9/25/2007	CD	B-NP	O
,	,	,	O	O
therapeutic	therapeutic	JJ	B-NP	O
paracentesis	paracentesis	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
ascitic	ascitic	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
removed	remove	VBN	B-VP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

Chemistries	Chemistry	NNS	B-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
ascitic	ascitic	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
laboratory	laboratory	NN	I-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
knee	knee	NN	I-NP	O
amputations	amputation	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
ascites	ascite	NNS	B-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
problem	problem	NN	B-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
paracentesis	paracentesis	NN	I-NP	O
with	with	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
fluid	fluid	NN	I-NP	O
revealing	reveal	VBG	B-VP	O
chemistries	chemistry	NNS	B-NP	O
with	with	IN	B-PP	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2.5	2.5	CD	B-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	O
ascites	ascite	NNS	I-NP	O
albumin	albumin	NN	I-NP	O
gradient	gradient	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1.1	1.1	CD	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
transudative	transudative	JJ	I-NP	O
ascites	ascite	NNS	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
with	with	IN	B-PP	O
resultant	resultant	JJ	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Ascites	Ascite	NNS	B-NP	O
had	have	VBD	B-VP	O
460	460	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
with	with	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
.	.	.	O	O

Ascitic	Ascitic	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	O	O
cytology	cytology	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ascitic	ascitic	JJ	I-NP	O
fluids	fluid	NNS	I-NP	O
identified	identify	VBD	B-VP	O
no	no	DT	B-NP	O
malignant	malignant	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

After	After	IN	B-PP	O
consultation	consultation	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ascites	ascite	NNS	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
massive	massive	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
undergo	undergo	VB	I-VP	O
reduction	reduction	NN	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
through	through	IN	B-PP	O
ultrafiltration	ultrafiltration	NN	B-NP	O
at	at	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
process	process	NN	I-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
,	,	,	O	O
efforts	effort	NNS	B-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
fluid	fluid	NN	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
during	during	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rates	rate	NNS	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
140s	140	NNS	I-NP	B-DNA
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
difficulties	difficulty	NNS	I-NP	O
with	with	IN	B-PP	O
removing	remove	VBG	B-VP	O
fluid	fluid	NN	B-NP	O
at	at	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
offered	offer	VBN	I-VP	O
the	the	DT	B-NP	O
option	option	NN	I-NP	O
of	of	IN	B-PP	O
undergoing	undergo	VBG	B-VP	O
ultrafiltration	ultrafiltration	NN	B-NP	O
by	by	IN	B-PP	O
CVVH	CVVH	NN	B-NP	B-protein
or	or	CC	O	O
an	an	DT	B-NP	O
ultrafiltration	ultrafiltration	NN	I-NP	O
machine	machine	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
declined	decline	VBD	B-VP	O
to	to	TO	I-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
such	such	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
despite	despite	IN	B-PP	O
our	our	PRP$	B-NP	O
efforts	effort	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
fluid	fluid	NN	B-NP	O
restrictions	restriction	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
put	put	VBN	I-VP	O
into	into	IN	B-PP	O
place	place	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diet	diet	NN	I-NP	O
order	order	NN	I-NP	O
,	,	,	O	O
therefore	therefore	RB	O	O
also	also	RB	B-ADVP	O
making	make	VBG	B-VP	O
it	it	PRP	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
ultrafiltration	ultrafiltration	NN	B-NP	O
at	at	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
dialysis	dialysis	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
remove	remove	VB	I-VP	O
fluid	fluid	NN	B-NP	O
and	and	CC	O	O
reduce	reduce	VB	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
communicated	communicate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
renal	renal	JJ	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Simon	Simon	NNP	I-NP	O
Esbrandt	Esbrandt	NNP	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
outpatient	outpatient	NN	I-NP	O
renal	renal	JJ	I-NP	O
attending	attend	VBG	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Archie	Archie	NNP	I-NP	O
Chhum	Chhum	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
ultrafiltration	ultrafiltration	NN	B-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
at	at	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
as	as	IN	B-NP	O
much	much	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
and	and	CC	O	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
state	state	NN	B-NP	O
.	.	.	O	O

Ultrafiltration	Ultrafiltration	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
attempt	attempt	VB	I-VP	O
to	to	TO	I-VP	O
counteract	counteract	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
were	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
given	give	VBN	I-VP	O
that	that	IN	B-SBAR	O
surgical	surgical	JJ	B-NP	O
revision	revision	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
planned	plan	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vascular	vascular	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Herb	Herb	NNP	I-NP	O
Piecuch	Piecuch	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
corrected	correct	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
undergoing	undergo	VBG	B-VP	O
surgical	surgical	JJ	B-NP	O
revision	revision	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
11/16/2007	11/16/2007	CD	B-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
by	by	IN	B-PP	O
echocardiogram	echocardiogram	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
and	and	CC	O	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
a	a	DT	B-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
volume	volume	NN	B-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
through	through	IN	B-PP	O
ultrafiltration	ultrafiltration	NN	B-NP	O
at	at	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
for	for	IN	B-PP	O
fear	fear	NN	B-NP	O
of	of	IN	B-PP	O
noncompliance	noncompliance	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
but	but	CC	B-PP	O
on	on	IN	B-PP	O
1/8/2007	1/8/2007	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
went	go	VBD	B-VP	O
into	into	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
with	with	IN	B-PP	O
rates	rate	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
120s	120s	CD	I-NP	B-DNA
to	to	TO	B-PP	I-DNA
140s	140s	CD	B-NP	I-DNA
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
accept	accept	VB	I-VP	O
monitoring	monitoring	NN	B-NP	O
on	on	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
telemetry	telemetry	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-VP	O
refused	refuse	VBD	I-VP	O
to	to	TO	I-VP	O
cooperate	cooperate	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
slowly	slowly	RB	I-VP	O
titrated	titrate	VBN	I-VP	O
upward	upward	RB	B-ADVP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
his	his	PRP$	B-NP	O
rate	rate	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
100s	100	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
optimally	optimally	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
refused	refuse	VBD	B-VP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
managed	manage	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
slow	slow	JJ	I-NP	O
readjustment	readjustment	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
fingersticks	fingerstick	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	O	O
nightly	nightly	RB	B-ADVP	O
basis	basis	NN	B-NP	O
with	with	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
below-the-knee	below-the-knee	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
need	need	VBP	B-VP	O
surgical	surgical	JJ	B-NP	O
revision	revision	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
after	after	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vascular	vascular	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Mel	Mel	NNP	I-NP	O
Bierut	Bierut	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
surgical	surgical	JJ	I-NP	O
revision	revision	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
addressed	address	VBN	I-VP	O
after	after	IN	B-SBAR	O
his	his	PRP$	B-NP	O
issues	issue	NNS	I-NP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
are	be	VBP	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
likely	likely	JJ	I-NP	O
paronychia	paronychia	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
index	index	NN	I-NP	O
finger	finger	NN	I-NP	O
.	.	.	O	O

Plain	Plain	NN	B-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
reveal	reveal	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
hand	hand	NN	I-NP	O
surgery	surgery	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
issues	issue	NNS	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
hand	hand	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
no	no	DT	B-NP	O
urgent	urgent	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
debridement	debridement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
finger	finger	NN	I-NP	O
was	be	VBD	B-VP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
taking	take	VBG	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
3-week	3-week	JJ	B-NP	O
course	course	NN	I-NP	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
on	on	IN	B-PP	O
6/11/2007	6/11/2007	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
finger	finger	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

PHYSICIAN	PHYSICIAN	NN	B-NP	O
FOLLOWUP	FOLLOWUP	NN	I-NP	O
PLANS	PLANS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
followup	followup	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
vascular	vascular	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Huey	Huey	NNP	I-NP	O
Lamond	Lamond	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
10/26/2007	10/26/2007	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
178-843-9703	178-843-9703	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
his	his	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Jamal	Jamal	NNP	I-NP	O
Gehlert	Gehlert	NNP	I-NP	O
,	,	,	O	O
telephone	telephone	NN	B-NP	O
#	#	#	I-NP	O
204-180-5657	204-180-5657	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
at	at	IN	B-PP	O
Gentville	Gentville	NNP	B-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
direction	direction	NN	I-NP	O
of	of	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Alphonso	Alphonso	NNP	I-NP	O
Berwald	Berwald	NNP	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Monday	Monday	NNP	I-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
schedule	schedule	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
14-day	14-day	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
on	on	IN	B-PP	O
6/11/2007	6/11/2007	CD	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
fourth	fourth	JJ	I-NP	O
finger	finger	NN	I-NP	O
paronychia/skin	paronychia/skin	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
upwards	upward	NNS	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
by	by	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
ultrafiltration	ultrafiltration	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
during	during	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
volume	volume	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PhosLo	PhosLo	NN	B-NP	O
1334	1334	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	B-protein
q.a.c.	q.a.c.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
14	14	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneous	subcutaneous	JJ	B-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
q.	q.	NN	I-NP	O
48h	48h	NN	I-NP	O
.	.	.	O	O

until	until	IN	B-PP	O
6/11/2007	6/11/2007	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Nephrocaps	Nephrocaps	RB	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lyrica	Lyrica	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
nightly	nightly	RB	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Zinc	Zinc	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
220	220	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-8793311	1-8793311	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BURSIK	BURSIK	NNP	B-NP	O
,	,	,	O	O
MICHAEL	MICHAEL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CHRISTIANSON	CHRISTIANSON	NNP	B-NP	O
,	,	,	O	O
COLBY	COLBY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6218454	6218454	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/20/07	8/20/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/20/07	8/20/07	CD	B-NP	O

